Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
58.61
-1.00 (-1.68%)
At close: Nov 13, 2024, 4:00 PM
59.26
+0.65 (1.11%)
After-hours: Nov 13, 2024, 5:52 PM EST
Halozyme Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 392.47 | 281.59 | 202.13 | 402.71 | 129.09 | -72.24 | Upgrade
|
| Depreciation & Amortization | 81.59 | 82.36 | 49.64 | 3 | 3.28 | 4.07 | Upgrade
|
| Other Amortization | 7.33 | 7.3 | 7.84 | 3.64 | 14.14 | 2.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.77 | 0.61 | 0.13 | - | -0.77 | 1.43 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 2.5 | - | - | 0.58 | 1.13 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.02 | -6.32 | 2.83 | 2.26 | 0.84 | -2.47 | Upgrade
|
| Stock-Based Compensation | 41.59 | 36.62 | 24.4 | 20.82 | 17.2 | 34.78 | Upgrade
|
| Other Operating Activities | 29.96 | 22.58 | 39.09 | -136.72 | -0.53 | -4.06 | Upgrade
|
| Change in Accounts Receivable | -68.42 | -3.34 | -83.94 | 6.76 | -38.29 | -29.44 | Upgrade
|
| Change in Inventory | -58.19 | -26.88 | -17.48 | 7.37 | -31.39 | -6.73 | Upgrade
|
| Change in Accounts Payable | -12.67 | -12.55 | 24.54 | 1.17 | -41.21 | 4.64 | Upgrade
|
| Change in Other Net Operating Assets | -1.47 | 4.1 | -9.06 | -11.56 | 2.52 | -19.01 | Upgrade
|
| Operating Cash Flow | 402.95 | 388.57 | 240.11 | 299.44 | 55.45 | -85.42 | Upgrade
|
| Operating Cash Flow Growth | 9.30% | 61.83% | -19.81% | 439.98% | - | - | Upgrade
|
| Capital Expenditures | -10.24 | -15.29 | -4.81 | -1.46 | -2.5 | -4.04 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 26.01 | - | 1.08 | - | Upgrade
|
| Cash Acquisitions | - | - | -999.12 | - | - | - | Upgrade
|
| Investment in Securities | -290.25 | -81.62 | 490.92 | -404.83 | 79.78 | -1.51 | Upgrade
|
| Investing Cash Flow | -300.49 | -96.91 | -487.01 | -406.29 | 78.35 | -5.55 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,072 | 784.88 | - | 447.35 | Upgrade
|
| Long-Term Debt Repaid | - | -13.48 | -447.45 | -369.06 | -19.56 | -108.08 | Upgrade
|
| Net Debt Issued (Repaid) | - | -13.48 | 624.55 | 415.81 | -19.56 | 339.27 | Upgrade
|
| Issuance of Common Stock | 29.93 | 7.88 | 14.05 | 12.54 | 63.39 | 14.22 | Upgrade
|
| Repurchase of Common Stock | -252.3 | -402.38 | -200 | -350.06 | -150.12 | -200 | Upgrade
|
| Other Financing Activities | - | - | -76.22 | -0.42 | - | -0.28 | Upgrade
|
| Financing Cash Flow | -222.37 | -407.99 | 362.37 | 77.87 | -106.28 | 153.22 | Upgrade
|
| Net Cash Flow | -119.91 | -116.33 | 115.48 | -28.98 | 27.52 | 62.24 | Upgrade
|
| Free Cash Flow | 392.71 | 373.28 | 235.3 | 297.98 | 52.95 | -89.46 | Upgrade
|
| Free Cash Flow Growth | 11.05% | 58.64% | -21.04% | 462.76% | - | - | Upgrade
|
| Free Cash Flow Margin | 41.45% | 45.01% | 35.65% | 67.22% | 19.79% | -45.65% | Upgrade
|
| Free Cash Flow Per Share | 3.02 | 2.78 | 1.67 | 2.03 | 0.37 | -0.62 | Upgrade
|
| Cash Interest Paid | 11.41 | 11.41 | 6.11 | 3.3 | 6.53 | 9.03 | Upgrade
|
| Cash Income Tax Paid | 31.76 | 31.76 | 16.22 | -0.38 | 0.18 | 0.19 | Upgrade
|
| Levered Free Cash Flow | 339.29 | 268.16 | 146.42 | 197.82 | 3.92 | -55.14 | Upgrade
|
| Unlevered Free Cash Flow | 343.69 | 272.58 | 149.17 | 198.88 | 2.52 | -50.35 | Upgrade
|
| Change in Net Working Capital | 67.38 | 43.64 | 100.95 | -4.08 | 105.63 | 42.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.